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Abstract
Background: Trabecular meshwork and Schlemm’s canal are the tissues appointed to modulate the aqueous humour
outflow from the anterior chamber. The impairment of their functions drives to an intraocular pressure increase. The
selective laser trabeculoplasty is a laser therapy of the trabecular meshwork able to decrease intraocular pressure. The exact
response mechanism to this treatment has not been clearly delineated yet. The herein presented study is aimed at studying
the gene expression changes induced in trabecular meshwork cells by selective laser trabeculoplasty (SLT) in order to better
understand the mechanisms subtending its efficacy.
Methodology/Principal Findings: Primary human trabecular meshwork cells cultured in fibroblast medium underwent
selective laser trabeculoplasty treatment. RNA was extracted from a pool of cells 30 minutes after treatment while the remaining
cells were further cultured and RNA was extracted respectively 2 and 6 hours after treatment. Control cells stored in incubator in
absenceofSLTtreatmentwereusedasreferencesamples.GeneexpressionwasevaluatedbyhybridizationonmiRNA-microarray
and laser scanner analysis. Scanning electron microscopic examination was performed on 2 Trabecular meshwork samples after
SLT at 4
th and 6
th hour from treatment. On the whole, selective laser trabeculoplasty modulates in trabecular meshwork the
expression of genes involved in cell motility, intercellular connections, extracellular matrix production, protein repair, DNA repair,
membrane repair, reactive oxygen species production, glutamate toxicity, antioxidant activities, and inflammation.
Conclusions/Significance: SLT did not induce any phenotypic alteration in TM samples. TM is a complex tissue possessing a
great variety of function pivotal for the active regulation of aqueous humour outflow from the anterior chamber. SLT is able to
modulatethesefunctionsatthepostgenomicmolecularlevelwithoutinducingdamageeitheratmolecularorphenotypiclevels.
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Introduction
Glaucoma is a neurodegenerative multi-factorial disease af-
fecting different target tissues: the lateral geniculate nucleus and
the visual cortex in the central nervous system, [1] the optic nerve
head in the retina, and the trabecular meshwork (TM) in the
anterior chamber (AC) of the eye. In the majority of cases the
glaucoma is accompanied by intraocular pressure increase that is
the most important risk factor for the progression of disease [2]. All
the pathogenic events leading to death of the retinal ganglion cells
(RGCs) are not yet known with accuracy but it is established that
TM play a major role in the glaucomatous pathogenic cascade.
The concept that eye outflow system is a passive filter is outdated.
Indeed Alvarado found that severe alterations occur in the cellular
component and in the entire TM during POAG and ageing [3,4].
The same author shown that TM endothelial cells regulate
aqueous outflow by actively releasing enzymes and cytokines that,
upon binding to Schlemm’s canal (SC) endothelial cells, increase
transendothelial flow thereby facilitating the egress of aqueous
humour [5]. TM endothelial cells secrete these factors in response
to stimuli such as mechanical stretching, laser irradiation, and
pro-inflammatory cytokines [6,7]. In 1991 Sacca ` et al. [8,9]
presented a new Argon Laser Trabeculoplasty (ALT) technique as
applied to TM that took advantage of a very low power thus not
creating burns in TM and being at the same time able to obtain a
lasting effect of IOP decrease in subjects suffering from glaucoma
(Figure 1). Some years later Latina et al. [10] employed a
q-switched 532-nm neodymium (Nd):YAG laser to investigate the
safety and efficacy of laser treatment. Laser parameters were set to
selectively target pigmented TM cells without coagulative damage
to the TM structure or nonpigmented cells. This technique was
called ‘‘selective laser trabeculoplasty,’’ (SLT) and decreased
intraocular pressure by an amount similar to that achieved with
standard trabeculoplasty [11]. Actually, SLT does not produce any
anatomic alteration appreciable to microscope while ALT cause
visible burns on TM (Figure 1). Anyway, SLT is equivalent to
ALT in terms of IOP lowering at 1 year and is a safe and effective
procedure for patients with open-angle glaucoma [12]. Indeed, the
exact response mechanisms to this treatment has not been clearly
delineated yet, even if it is known that energy laser has many
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energy used and the distance from the center of the irradiated zone
[13]. One biologic response of the trabecular meshwork after laser
trabeculoplasty is a change in the level of ongoing trabecular cell
division [14]. This is the basis of the ‘‘repopulation theory’’ stating
that laser would stimulate the repopulation of the meshwork with
fresh trabecular cells, which may result in the formation of healthy
TM [15]. The ‘‘biological theory’’ suggests that the mechanism of
action of ALT or SLT is based on the release of cytokines and
synthesis of matrix metalloprotease enzyme from TM cells in-
duced by the heating effect of the laser and finally resulting in an
increased turnover of the extracellular matrix [16,17].
The first ‘‘mechanical theory’’ stating that the laser application
results in the local shrinkage of the meshwork, opening the inter-
trabecular spaces between the laser sites [18] has been nowadays
neglected by most of the authors.
SLT applied on rabbit eyes increases in aqueous humour lipid
peroxidase and free oxygen radicals levels [19]. Accordingly, it is
conceivable that SLT induces a transient and moderate cell stress
triggering cellular defences without coagulative damage to the
TM [20]. In order to explore this hypothesis and gene-expression
changes preceeding SLT effects, we performed the herein pre-
sented study aimed at studying the gene expression changes
induced in TM cells by SLT.
The study adhered to the tenets of the Declaration of Helsinki
and was approved by the Ethical Board of the Ophthalmologic
Division.
Results
SLT did not induce any phenotypic alteration in TM samples
collected from corneal donors as evaluated by electron scanning
microscopy either 3 h and 6 h after treatment (Fig. 1 a and c). By
comparison, this lack of phenotypic effect is completely different
from the remarkable tissue alterations induced by trabeculoplasty
treatment in analogue sample after 3 h since treatment (Fig. 1 b).
Conversely, SLT induced important changing at postgenomic
level in TM cells.
SLT treatment induced a time-related change in the gene
expression profile of TM cells. As evaluated by scatter plot such a
change was well detectable starting since two hours after SLT
treatment and persisted up to 6 hours (Fig. 2, upper panel).
Changes of gene expression induced by SLT were time dependent,
being mainly detectable after 2 and 6 hours since SLT exposure,
and included both upregulation of genes expressed at low levels in
Control (blue lines) and dowregulation of genes expressed at high
level in Control (red lines) (Fig. 2, lower panel). The modulating
effect on the global gene expression profile was pointed out by
hierarchical cluster analysis demonstrating that gene expression
profile of Control and SLT-treated TM cells after 30 min are
similar and clustered together in the same dendrogram branch
(Fig. 2, upper panel, left side). Conversely, gene expression profile
of SLT-treated TM cells after 2 and 6 hours are remarkably
different from Control being located in different branches of the
dendrogram (Fig. 3, upper panel, right side). A similar situation
was recorded by performing Principal Component Analysis of
variance where Control and SLT-treated TM cells after 30 min
(T0.5) are located in the same quadrant, while SLT-treated TM
cells after 2 hours (T2) and 6 hours (T6) are located in different
quadrants far away from Control (Fig. 3, lower panel).
Scatter plot analysis identified those genes up- or down-
regulated by SLT after 30 min (T0.5), 2 hours (T2) and 6 hours
(T6) (Fig. 4).
No effect was observed after 30 min since SLT treatment.
Conversely, after 2 hours the number of genes changing their
expression more than 2-fold as compared to controls accounted for
513, further rising up to 3,774 after 6 hours.
Out of the 94 genes spotted on the microarray activating cell
death by apoptosis or necrosis no one significantly varied its
expression as consequence of SLT. This finding demonstrates that,
under our experimental conditions, SLT does not induce directly
per se cell damage. This finding is in line with the lack of any
Figure 1. Trabecular meschwork after SLT and ALT. Scanning
electron microscope photograph of the human sclerocorneal trabecular
meshwork (magnification 2,000x in A and C, and 1,500x in B) 3 h (A) and
6 h (C) after SLT treatment. The architecture of TM is well conserved,
showing intact trabecular beams (A,C). By comparison, following argon
laser trabeculoplasty a coagulative damage with disruption of
trabecular beams is well evident (B).
doi:10.1371/journal.pone.0020110.g001
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electron microscopy (Fig. 1).
Among the many genes changing their expression, statistical
support vector machine analysis identified 67 predictor genes
specifically and significantly related with SLT treatment.
These genes, detailed in Table S1, online supporting informa-
tion, are involved in various cell functions including cell motility,
tissue integrity, cell membrane components, mitochondrion func-
tion, oxidative stress, DNA repair, glutamate metabolism, inflam-
mation, and energy production.
Complete microarray data are available at GEO database
(GEO number GSE29697) (http://www.ncbi.nlm.nih.gov/geo/).
Discussion
Our work provides evidence at postgenomic level that TM
actively modulates the aqueous humor outflow through a variety
of molecular mechanisms that can be modulated by SLT.
TM motility
Of the 67 genes modulated by SLT 7 (12%), encoding for
activities involved in cell motility and contraction were upregu-
lated by SLT indicating that this treatment enhance the
contracting capacity of TM cells. The contractile function, cell
shape, and cell adhesion properties of TM and SC cells have been
Figure 2. Quantitative analysis of TM Gene expression after SLT. Box plot (upper panel) and time course (lower panel) analyses of the
expression of 18,401 genes in TM cells either unexposed (Control) or after various times (0.5, 2, and 6 hours) since SLT treatment. Box plot analysis
report the level of expression of each gene (dot) located on vertical axis according to its level of expression expressed on a color scale referred to
control (blue low expression, red high expression). Time course analysis reports the variation in the gene expression intensity for each analysed gene.
Genes undergoing downregulation after SLT treatment as compared to control are indicated in blue, genes undergoing upregulation in red.
doi:10.1371/journal.pone.0020110.g002
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through the conventional pathway [21,22]. Indeed, contraction
of TM with its smooth muscle-like properties, decreases outflow,
whereas relaxation increases this parameter [23]. This tissue has
the ability to contract when exposed to appropriate stimulants
[23], its property is important in helping regulate the outflow of
aqueous humor [24]. Indeed, Trabecular meshwork cells express
contractile elements such as smooth muscle a-actin and myosin
[25]. F-actin architecture in human outflow pathway cells in situ
differs between normal and glaucoma eyes, glaucomatous tissue
showing a more ‘‘disordered’’ actin architecture overall [26]. TM
and its endothelial cells, as well as SC Schlemm‘s canal and the
lining endothelial cells, undergo deformation and stretching with
changes in intraocular pressure [5].
The above reported results could confirm the hypothesis of the
‘‘mechanical theory’’ of Wise and Witter [18], neverthenless also
the ‘‘biological theory’’ [16,17] and the ‘‘repopulation theory’’
[15] are almost supported by our findings.
Tissue integrity
Indeed, 15 out of the 67 genes (22%) modulated by SLT
encoded for activities involved in maintaining TM tissue integrity.
Among these, genes involved in adherence to basal membrane and
intercellular connection and in extracellular matrix removal
resulted up regulated. Conversely, SLT downregulated gene in-
volved in the production of extracellular matrix. These mecha-
nisms contributes to the maintenance of TM cellularity counter-
acting its decrease. It was demonstrated that a relative increase in
the extracellular matrix/cells ratio is crucial for POAG progres-
sion [27]. IOP homeostasis, triggered by pressure changes or
mechanical stretching of the TM, appears to involve the extra-
cellular matrix turnover [28]. An upregulation of genes involved in
repairing and removing damaged protein was observed. This
finding indicate that SLT increase removal of oxidized proteins
typically accumulating in degenerating and aged tissues [29].
Cell membrane
Furthermore 8 out of 67 genes whose expression was affected by
SLT treatment are cell membrane components. Genes encoding
for activities involved in intracellular Ca
++ homeostasis were
modulated by SLT. This finding probably reflects the SLT effect
on mitochondrion (see below), which is the main intracellular Ca
++
Figure 3. Qualitative analysis of TM Gene expression before
and after SLT. Hierarchical cluster (upper panel) reporting gene
expression profile as evaluated in TM cells before SLT (Control, left
column) and at various times after SLT (0.5, 2, 6 h). Gene expression
intensity is reported as color scale (blue low, red high). The same gene
expression profile was compared among different experimental con-
ditions (dots) by analyzing the two principal components of variance for
each sample (PCA) (lower panel).
doi:10.1371/journal.pone.0020110.g003
Figure 4. Comparative analysis of TM Gene expression before and after SLT. Scatter plot analysis comparing gene expression before
(vertical axis, Control) and after SLT at various times (horizontal axis, 0.2, 2, 6 h). Gene expression intensity is reported as color scale referring to
Control (blue low, red high). The diagonal lines indicate the 2-fold variation interval including genes whose expression did not change after SLT.
Genes falling above these lines were downregulated, genes falling below these lines were upregulated more than 2-fold in their expression by SLT.
doi:10.1371/journal.pone.0020110.g004
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++ release is a pivotal step of the intrinsic
apoptotic pathway. Thus this situation may be interpreted as a
decreased trend towards apoptosis.
A study [30], examined the levels of Ca2+ in TM cells from
POAG and nondiseased aged-matched individuals and demon-
strated that both [Ca2+]c and [Ca2+]m were higher in POAG
TM. POAG TM cells have defective mitochondrial function,
which causes them to be abnormally vulnerable to Ca
2+ stress.
The dysfunction in calcium regulation by these cells may con-
tribute to the failure of this tissue to control IOP.
SLT treatment increased the expression of genes encoding for
cell growth factor, aminoacids, and Na
+ uptake. On the whole
these genes contribute to tissue integrity by stimulating cell growth
and volume maintenance. SLC3A2, involved in the synthesis of
nitric oxide, was upregulated. This indicates that SLT activates
mechanisms contributing to the maintenance of TM integrity such
as blood perfusion improvement, being nitric oxide able to
increase vessel diameter and perfusion rate.
Mitochondria
8 out of the 67 (12%) SLT-modulated genes were involved in
mitochondrial functions. 7 of these genes, involved in ion transport
and lipid peroxidation, were downregulated. This trend indicates
a silencing of mitochondrial activities producing intracellular re-
active oxygen species. However this situation does not result in
energy shortage. In fact a gene (ATP5J) involved in ATP synthesis
was upregulated.
Energy production
Furthermore, among 6 genes involved in energy production
(9% of 67), 3 genes, involved in glucose supply and anaerobic
glycolysis, were upregulated. In parallel, 3 of these genes, involved
in ATP consumption, were downregulated. These finding indicate
that TM cells as a consequence of SLT exposure decrease energy
consumption and increase energy production by anaerobic mecha-
nisms. This balance results in the reduction of endogenous pro-
duction of reactive oxygen species.
Oxidative stress
8 out of 67 genes (10%) affected by SLT treatment are involved
in response to oxidative stress and production of antioxidant
activities. Upregulated antioxidant activities include glutathione,
cyestine rich proteins, bilirubin metabolites, mitochondrial cyto-
chrome. Two genes involved in removal of retinol derivatives were
downregulated, suggesting that retinol metabolites too contribute
to the increasing of the antioxidant status.
The role of reactive oxygen species in the pathogenicity of
glaucoma is supported by increasing evidences [31]. Indeed,
oxidative damage to the DNA of TM cells has been proved to be
significantly higher in affected patients than in age-matched con-
trol subjects [32]. Oxidative damage and AH antioxidant defects
mainly targets TM, which the most sensitive tissue of the anterior
chamber to oxidative damage [33].
DNA
Moreover an increased trend to DNA repair was observed. In
fact among the 5 (7% of 67) genes involved in DNA repair and cell
cycle, 2 involved in base repair and 1 inhibiting cell cycle were
upregulated, while 3 inducing cell cycle progression were down-
regulated. This figure indicates a trend to cell cycle rate decrease
paralleled by increased DNA repair.
Luna et al. [34] demonstrated that chronic oxidative stress may
lead to increased synthesis and deposition of extracellular matrix
in the TM and contribute to the elevation of intra-ocular pressure
in glaucoma. Thus the trend toward oxidative damage reduction
herein reported could act in synergism with the above underlined
mechanisms of manteinance of the homeostasis between cells and
extracellular matrix.
Inflammation
All the 7 genes (10% out of 67) involved in inflammation and
recruitment of inflammatory cells were downregulated after SLT
treatment. This situation results in an immunosuppressive effect
bearing relevance because inflammation has been proposed as a
possible pathogenic step of POAG. These findings are in line with
the ability of light to induce immunosuppression by modulating
gene expression in exposed tissues [35]. Alvarado et al. [36]
reported an increased expression of IL 8 in cultured TM cells
treated with SLT. Unfortunately this data is not assessable in our
study, the sequence of its gene not being present in our array.
Furthermore Alvarado et al. recently demonstrated a monocyte
recruitment in TM following SLT treatment [6] confirming a
involvement of immunologic response to SLT treatment.
Glutamate metabolism
3 out of the 67 genes modulated by SLT (4%) are involved
in glutamate metabolism. This confirm a possible interaction
between glutamate metabolism and the IOP in the optic nerve
head where, in rabbits, the elevation of the IOP causes an increase
in the glutamate levels [37]. Indeed, acute and transient intra-
ocular hypertension induces neurodegenerative changes and the
accompanying glial activation in the visual pathway. Brain
changes may occur in parallel with the Retinal Ganglion Cells
loss. Reactive glial cells in the brain may participate in the
clearance of aberrantly released glutamate [38].
TM gene expression
The expression of 9 genes (13%) characterizing neural tissue,
as inferred from Swissprotein annotation, was well detectable
expressed in TM cells and modulated by SLT treatment. These
genes are identified by ‘*’ in Table S1. This finding indicate that
similarities at postgenomic levels exist between TM and other
neural tissues recognized as POAG targets such as optic nerve
head and geniculate ganglion. TM cells have a neuro-ectodermic
origin, expressing, at least in part, a neural-like phenotype [39]
TM cells derive from mesenchymal cells of the neural crest [40].
This may explains why the SLT increases also the genes ex-
pression of typical neural tissues, and further confirm the similarity
between TM and neural tissue previously reported comparatively
analyzing proteome in TM and optic nerve head [41,42,43].
Furthermore, neural proteins have been specifically detected in the
aqueous humour of glaucomatous patients as resulting both from
TM and optic nerve head damage and these molecules may be
involved in the normal formation and function of these tissues
[44].
The similarity between TM and neural tissue is important for
glaucoma pathogenesis because they can share common patho-
genic mechanisms. The herein reported results provide evidence
that glutamate cytotoxic effects representing a major pathogenic
element for nerve tissues targeted by glaucoma, are also important
for TM homeostasis and may be modulated in TM by SLT
treatment. A trend to decreasing TM cell to the adverse glutamate
effects was detected. In fact, SLT decreased the expression of gene
encoding for the NMDA glutamate receptors, which mediate
glutamate induced cytotoxicity. In parallel, two genes encoding for
enzymes involved in glutamate catabolism were upregulated.
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intercellular connections, decreased extracellular matrix produc-
tion, protein repair, DNA repair, membrane repair, decreased
reactive oxygen species production, decreased glutamate toxicity,
increased antioxidant activities, and decreased inflammation.
Nevertheless it has to be taken into account that the analysis of
gene expression can give a broad quantity of data but not all of
them will be actually effective in cell. As a matter of that Alvarado
et al. [36] pointed out that only a small portion of the differentially
expressed genes are actually involved in the SLT mediated effects.
Further analyses of the SLT induced modulation of the mirnoma,
in progress in our laboratory, will contribute to give a more
detailed picture of the mechanisms subtending the SLT efficacy
and will improve the understanding of the pathogenic events of
POAG. Even if the mechanism underlying contraction or relaxa-
tion of TM cells in vivo is not clear, it is thought that a high IOP,
can extend the trabecular beams, obtaining an increased exposure
of endothelial cells in AH by increasing the surface of filtration
[44] and a cytokines increase into the AC that then will increase
flow across the SC [36]. If the IOP falls below the venous pressure,
the surface of filtration decreases and the trabecular beams
become flaccid, increasing the residence to the outflow of SC [36].
Extracellular matrix proteins contribute to the homeostatic modi-
fication of aqueous humor outflow resistance and are known to be
upregulated or downregulated in response to mechanical stretch-
ing [45,46]. Our results indicate that SLT activate at least one
gene encoding for a metalloprotease involved in extracellular
matrix homeostasis (ADAMTS2). Other cellular changes may
initially help to repair mechanical damage, and could eventually
increase tissue rigidity and compromise the ability of the TM to
maintain normal levels of outflow resistance [47]. TM cell
adhesions, are not static structures but rather are dynamic – they
come and go, vary in tightness, location, adhesivity – depending
on what is going on in the environment of the cell [48]. SLT
change this TM property, changing the proteins production not
only structural that govern the TM functionality, in particular the
assembly and disassembly of the junctions and the interactions of
the cytokines that influencing the HA outflow between the TM
and SC endothelium. Thus, the tri-dimensional architecture of
human TM considerably increases the filtration surface, whose
degeneration, resulting in the decay of HTM cellularity, causes
IOP increase and triggers glaucoma pathogenesis [4]. According
with Borras [41] model, the cells of the outflow pathway will
initially respond to an IOP insult by triggering a defense mecha-
nism through the activation of NF-kB. As the injury persists, as it is
the case in a chronic disease, the increased activation of NF-kB will
subsequently be followed by further activation of inflammatory
cytokines that would then contribute to the cell damage observed
in glaucoma. Particularly, chronic oxidative stress leads to the
endogenous production of ROS by the mitochondria in TM cells,
which in turn induces a sustained stress response characterized by
activation of NF-kB and expression of inflammatory markers [49].
ROS present in AC can cause an error of replication of mtDNA
determining a significant deletion of the mithocondria genome.
The genome shorter replicates itself faster inducing the creation of
mitochondria malfunctioning or inactive that causes an energy
deficit and atrophy [50], farther mitochondria are key regulators
of apoptosis [51]. The SLT lead the expression of distinct sets
of genes that stimulates an improvement of TM perfomances,
activating, as we have seen, genes concern the motility and the
integrity of this tissue and trying to optimise the functioning of
mitochondria in contrast to free radicals.
For instance, Bone morphogenetic proteins that controls mul-
tiple functions in a variety of cells are present in human optic nerve
head (ONH) tissues, isolated ONH astrocytes, and Lamina
Cribrosa cells [52], and can alter TGF-beta2 signaling in the
TM and leads to increased ECM deposition and elevated IOP
[43]. Our study confirm that glaucoma is associated with increased
expression of genes that mediate axonal outgrowth, immune res-
ponse, cell motility, neuroprotection, and ECM remodeling, and
as glaucoma progresses, retinal ganglion cell axons may make
a regenerative attempt to restore lost nerve cell contact [53].
Interestingly, some of the same genes have been reported to
have an upregulated expression in the TM and lamina cribrosa
cells treated with TGF, dexamethasone, mechanical stretch, or
increased ocular pressure [22,41,42,43,45]. Furthermore, neural
proteins have been specifically detected in the aqueous humour of
glaucomatous patients as resulting both from TM and optic nerve
head lamina cribrosa [39] in fact an increase in IOP resulted in
morphological changes in the astrocytes [54], in a disturbances in
axonal transport [55] and lead to a cytoskeletal damage in the
prelaminar, lamina cribrosa, and postlaminar regions of the optic
nerve, after 6 hours of raised IOP [56]. Under this light we can
observe the gene expression correlated with glutamate metabo-
lism. We know there is a way from AC and lamina cribrosa
through the iris and the choroidal vessels posteriorly, [57], that
may be related to glutamate receptor subunits regulating calcium
fluxes, the specific pattern of neuronal vulnerability [58]. It is
possible that Ionotropic glutamate receptor. L-glutamate acts as
an excitatory neurotransmitter at many synapses in the central
nervous system, bringing signals to the optic nerve head and
leaving the vitreous relatively inert. Therefore the TM is to be
considered as a organ that governs the flow from AC to SC whose
functions are complex, and not unrelated to those of ciliary body
whose physiopathologic meaning is now compared to a multi-
functional neuroendocrine gland [59]. Anyway, it is to remember
that both Aqueous Humour and plasma homocysteine levels were
significantly increased in POAG, and this is a neurotoxin that
induces apoptotic retinal ganglion cell death via stimulation of
NMDA receptor, hence increased Hcy concentrations in AH
and plasma might contribute to the optic nerve damage in
POAG [60].
In conclusion SLT significantly increased the tonographic
outflow facility and decreased IOP in patients with primary open
angle glaucoma and ocular hypertension [61], thanks to trabecular
gene-activations which involves a huge number of genes that affect
mainly its metabolic functions and its micro environment. These
protective effects occur without the induction of damage-related
phenotypic alterations in treated TM specimens, as documented in
Fig. 1.
For their absolute interest are those related to stress oxidative
which confirm its pathogenetic importance [62], and those related
to mitochondrial that confirm their primary role in TM function
[63] and in the entire homeostasis of AC. The similarity between
TM and neural tissue is important for glaucoma pathogenesis
because they can share common pathogenic mechanisms. Indeed,
herein reported results provide evidence that glutamate cytotoxic
effects representing a major pathogenic element for nerve tissues
targeted by glaucoma, are also important for TM homeostasis and
may be modulated in TM by SLT treatment. Recently, our group
has published a paper where it shows how the proteomic com-
position of aqueous humor reflects events of glaucoma pathogen-
esis [64]. In light of this presented results provide evidence that
TM is a complex tissue possessing a great variety of function
pivotal for the active regulation of aqueous humour outflow from
the anterior chamber. SLT is able to modulate these function at
postgenomic molecular level without inducing damage either at
molecular of phenotypic level.
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TM cell culture
Primary human TM cell line [HTM, ScienCell, San Diego,
California: cat. n. 6590, see http://www.sciencellonline.com for
details] were cultured in fibroblast medium (FM, ScienCell), 2%
fetal bovine serum (FBS, ScienCell), fibroblast growth supplement
(FGS, 1%, ScienCell) and penicillin/streptomycin solution (P/S,
1%, ScienCell) using poly-L-lysine-coated flasks having a 6 mm
diameter. Cell were growth to semi confluence accounting for
approximately 1610
5 cell per well. When reaching semi-con-
fluence cells underwent SLT treatment.
Selective laser trabeculoplasty treatment
TM cells underwent SLT under similar conditions usually
adopted for human subjects using a SLT laser system (Laserex
Tango Ellex Medical Pty Ltd – Australia). Specific treatment
conditions were Q-swithched frequency doubled with Nd:YAG
laser at 532 nm.
Wavelength, energy settings at 0.5 mJ single pulse, pulse
duration 3 nsec, and treatment spot size of 400 micron.
After treatment cells were immediately restored in incubator
and then collected by scraping after 30 min (T0.5), 2 hours (T2),
and 6 hours (T6). Control cells stored in incubator in absence of
SLT treatment were used as reference samples.
Scanning electron microscopic examination (Siemens Elmiskop
101; Siemens AG, Berlin, Germany) were performed on 2
Trabecular meshwork samples after SLT at 4
th and 6
th hour
from treatment (Figure 1). Immediately after laser light exposition,
all samples were immersed in cold antioxidant chondroitin sulfate/
dextran storage medium (Optisol, Chiron Vision, Irvine, Califor-
nia), coded blindly, and frozen at 280uC. Trabecular meshwork
samples were collected from two corneal donors in collaboration
with the Melvin Jones Eye Bank of Genoa, Italy.
Gene expression analysis by cDNA microarray
The expression of 18,401 human genes was tested in SLT-
treated cells by cDNA microarray. Custom microarray as made
available from the Microarray Department-University of Amster-
dam, were used. The whole list of spotted genes is available at the
website http://www.micro-array.nl/libraries.html. Because of the
poor amount of available cell extracted RNA underwent reverse
transcription and pre-plateau amplification as previously reported
[65].
All data is MIAME compliant and that the raw data has been
deposited in a MIAME compliant database (e.g., ArrayExpress,
GEO), as detailed on the MGED Society website http://www.
mged.org/Workgroups/MIAME/miame.html
Purified RNA underwent reverse transcription and amplifica-
tion using quantitative real-time PCR (qPCR) prior to probe
synthesis for array hybridization. A particular retrotranscription
protocol (SuperSMART, Clontech, Palo Alto, CA, USA) aimed
at the introduction of a target sequence at 39 and 59 of the cDNA
library was applied as follows: RNA was incubated with a mix
of a target sequence-oligo(dT)-linked primer and a target
sequence-oligo(dG)-linked at 72uC for 5 minutes then a master-
mix solution was added containing reverse transcriptase and
dNTPs mix. Samples were then incubated at 42uC for 90
minutes. Reaction was terminated by adding ethylenediamine-
tetraacetic acid, mixture diluted in phosphate buffer and syn-
thesized cDNA purified by column chromatography using a
commercially available purification kit (QIAquick PCR purifi-
cation kit, Qiagen, Chatsworth, CA, USA). A PCR mix,
including the specific primer for the target sequences and the
fluorescent tracers SYBR GREEN, was added to the purified
cDNA. The PCR reaction was performed at 95uC61m i n u t e ,5 0
amplification cycles at 95uC 615 s, 65uC 630 s and 68uC 63
minutes. The amplification curve was observed in real time by
recording fluorescence and the pre-plateau amplification cycle
was identified for each sample. A second set of sample was
amplified to the identified pre-plateau cycle using the same
conditions without the fluorescent tracer. This procedure was
applied to all samples in order to standardize the amplification
process thus allowing reliable comparisons of microarray data
among different samples. PCR reactions were performed in a
thermocycler equipped with microvial rotating support (Rotor-
gene, Corbett Research, Mortlake, Australia).
2 ug of amplified cDNA, as purified by column chromatog-
raphy, were converted in aminomodified probes performing a
t h r e ec y c l eP C Ru s i n gaP C Rm i xc o n t a i n i n gN - 1 8r a n d o m
primers, aminomodified dNTPs and Taq polymerase. The
reaction was performed at 95uC 65minutes, 94uC 61m i n u t e ,
25uC 690 s, 50uC 610 minutes and 68uC 65m i n u t e s .S y n -
thesized amino-modified oligo-nucleotides were purified by
column chromatography and alcohol precipitation then labelled
with fluorescent tracers Cy3 or Cy5 by incubation at room
temperature in the dark for 90 minutes. Fluorescent oligonu-
cleotides were precipitated by cold ethanol and sodium acetate,
and then purified by column chromatography. The efficacy of
the procedure was checked by spectrophotometric analysis
measuring abosorbance at 550 (Cy3) and 650 (Cy5). Standard-
ized amounts of labelled probes were hybridized on glass cDNA
microarrays.
Probes were lyophilized, diluted in 4 ul of EDTA 10 mM and
incubated at 95uC for 10 min. Hybridization solution (18 ul) was
added and labelled probe mixed together to a final volume of
44 ul. Mixture was then transferred onto microarrays which were
then covered with a coverslip and hybridized overnight at 50uCi n
a Hybridization Cassette (Life Technologies, Carlsbad, CA, USA).
After 16 hours the microarrays were washed twice in a low
stringency wash buffer (2X SSC, 0.5% SDS) and twice in a high
stringency wash buffer (0.5X SSC, 0,5% SDS). Microarray were
dried in centrifuge and signal acquired in a laser scanner
(ScanArray, PerkinElmer, Waltham, MA,USA).
Data analysis was performed subtracting for each microarray
the local spot background from raw spot intensity, log transfor-
mation, normalization per chip and per array (GeneSpringH
software version 7.2, Agilent Technologies, Santa Clara, CA).
Each gene was spotted in quadruplicate on the used microarray.
Accordingly, results represent the mean among 4 data. Data
generated for each mRNA were compared among the various
experimental groups by volcano-plot analysis taking into account
as thresholds of two-fold variation and statistical significance
P,0.05 as evaluated by ANOVA after Bonferroni multiple testing
correction. Global mRNA expression profiles were compared by
hierarchical cluster analysis (HC) and bidimensional principal
component analysis of variance (PCA).
Gene function was inferred from annotation reported in gene
databank (Weizmann Institute, www.genecards.org) and Swis-
sprotein database (http://expasy.org/sprot/).
‘‘Biological function of genes whose expression was modulate by
SLT was inferred from data available on Swissprot (http://expasy.
org/sprot/) and Weizmann Institute (http://www.genecards.org/)
databases. Predictor genes were identified by statistical support
vector machine analysis, which is a supervised learning methods
that predicts, for each given input, which of possible classes the
input is a member of identifying the most relevant genes affecting
this classification’’.
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